[Enterohepatic circulation in liver diseases].
D000818:Animals; D001463:Barbiturates / Q000378:metabolism; D001647:Bile Acids and Salts / Q000378:metabolism; D001711:Biotransformation; D001726:Bisacodyl / Q000378:metabolism; D002701:Chloramphenicol / Q000378:metabolism; D002779:Cholestasis / Q000503:physiopathology; D004074:Digitoxin / Q000378:metabolism; D004764:Enterohepatic Circulation / Q000187:drug effects; D006801:Humans; D008103:Liver Cirrhosis / Q000503:physiopathology; D008107:Liver Diseases / Q000503:physiopathology*; D009355:Neomycin / Q000494:pharmacology; D010672:Phenytoin / Q000378:metabolism; D051381:Rats; D013148:Spironolactone / Q000378:metabolism
D001463:Barbiturates; D001647:Bile Acids and Salts; D001726:Bisacodyl; D013148:Spironolactone; D010672:Phenytoin; D002701:Chloramphenicol; D004074:Digitoxin; D009355:Neomycin
Enterohepatischer Kreislauf bei Lebererkrankungen.